Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3

Clinical trial NCT07595874 · RECRUITING

Trial details

NCT number: NCT07595874
Sponsor: City of Hope Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Colon Adenocarcinoma Advanced Colorectal Adenocarcinoma Advanced Rectal Adenocarcinoma Stage IIB Colon Cancer AJCC v8 Stage IIB Rectal Cancer AJCC v8 Stage IIC Colon Cancer AJCC v8 Stage IIC Rectal Cancer AJCC v8 Stage IIIA Colon Cancer AJCC v8 Stage IIIA Rectal Cancer AJCC v8 Stage IIIB Colon Cancer AJCC v8 Stage IIIB Rectal Cancer AJCC v8 Stage IIIC Colon Cancer AJCC v8

Start date: 2026-12-27
Primary completion: 2027-05-27
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.